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1. To examine the effects of high insulin levels (100 nM) on 
phosphorylation of Insulin Receptor in cancerous 
MDA-MB-231 and normal  breast epithelial MCF-10a cells. 
2. To examine activation of PI3-kinase and MAP-kinase cell
signalling pathways after insulin treatment.
3. To examine cell proliferation in cancerous MDA-MB-231 and 
normal  breast epithelial MCF-10a cells after insulin 
treatment. 
4. To examine the role of PI3-kinase and MAP-kinase cell
signalling pathways in cell proliferation.
Recent findings suggest a connection between obesity and breast
cancer. Obesity is linked with higher incidences of insulin
resistance as part of the metabolic syndrome, resulting in
chronically elevated insulin plasma levels. We examined the
effect of high insulin concentrations (100 nM) on estrogen-
receptor (ER) negative breast cancer cells (MDA-MB-231) and
normal breast epithelial cells (MCF-10a).
Treatment with high insulin concentrations increased insulin
receptor (IR) phosphorylation significantly in both cell lines.
Phosphorylation of protein kinase B (Akt), representative of PI3-
kinase cell signalling pathway activation was increased by 101%
(p=0.0112) in MDA-MB-231 cells and by 81% (p=0.0031) in MCF-
10a cells after 10 min insulin treatment. Phosphorylation of
extracellular regulated kinase 1/2 (ERK1/2), representative of
MAP-kinase cell signalling pathway activation did not change in
both cell lines after 10 min of insulin treatment. Cell proliferation
did not change in MDA-MB-231 cells and increased by 75%
(p=0.0067) in MCF-10a cells after 24 h insulin treatment. Cell
proliferation was decreased in MDA-MB-231 cells by 15%
(p=0.0083) after 24 h treatment with PD98059, a MAP-kinase
inhibitor. In MCF-10a cells cell proliferation was decreased by
51% (p<0.0001) after 24 h treatment with wortmannin, a PI3-
kinase inhibitor and by 56% (p=0.236) after 24 h treatment with
PD98059.
These preliminary findings suggest that insulin resistance may
increase carcinogenesis of breast epithelial cells but may not
increase cancer progression in ER-negative breast tumours. Both
the PI3-kinase and MAP-kinase pathway may be responsible for
mediating insulin induced cell proliferation. Further studies are
needed to verify the involvement of the MAP-kinase pathway in
cell proliferation in MDA-MB-231 cells.
1. High insulin levels affect both cancerous MDA-MB-231 cells and normal breast 
epithelial MCF-10a cells.
2. Activation of Insulin Receptor, PI3-kinase and MAP-kinase cell signalling 
pathways is higher in cancerous MDA-MB-231 cells than in normal breast 
epithelial MCF-10a cells.
3. But only normal breast epithelial MCF-10a cells respond to high insulin 
stimulation with increased cell proliferation, pointing to a role of insulin 
resistance in breast cancer initiation.
4. High insulin levels stimulate cancerous MDA-MB-231 cells, but the 



































High insulin levels and Insulin Receptor phosphorylation
ELISA kits were used to measure IR phosphorylation after 2 min treatment with 
100 nM Insulin
High insulin levels and PI3-kinase cell signalling pathway activation
ELISA kits were used to measure protein kinase B (Akt) phosphorylation after 5-10 
min treatment with 100 nM Insulin
High insulin levels and MAP-kinase cell signalling pathway activation
ELISA kits were used to measure ERK1/2 phosphorylation after 5-20 min treatment 
with 100 nM Insulin
High insulin levels and cell proliferation
BrdU-incorporation was used to measure cell proliferation after treatment for 
24 h with 100 nM Insulin alone or in combination with either 100 nM 
wortmannin or 50 µM PD98059.
All experiments are expressed as mean sem of three experiments with two replicates 
(n≥6), except BrdU (n≥18). T-test has been used to compare control to treatment.
* p<0.05; *** p<0.001
